Important Safety Information
See Important Safety Information, including Boxed Warning, about:
Do not use semaglutide if:
If you are unsure whether any of these apply to you, speak with your healthcare provider before starting treatment.
Semaglutide is typically administered as a once-weekly subcutaneous injection.
The medication may be injected into the:
It may be taken with or without food. In many treatment plans, the dosage may be gradually adjusted over time depending on your provider’s clinical guidance.
Do not change your dose or stop treatment without first speaking with your healthcare provider.
Semaglutide may interact with other medications. Be sure to tell your provider about all medications and supplements you take, including:
Certain medications may require additional monitoring, including:
Semaglutide may slow stomach emptying, which can affect how some oral medications are absorbed.
Tell your provider if you have ever had:
Sharing your full medical history helps ensure the safest treatment plan.
Tell your provider if you are:
Semaglutide should not be used during pregnancy, as weight loss during pregnancy may pose risks to an unborn baby.
Because semaglutide may remain in the body for an extended period, treatment is typically discontinued at least two months before a planned pregnancy.
If you are breastfeeding or planning to breastfeed, discuss the best feeding options with your provider before starting treatment.
Seek immediate medical care if you experience symptoms of a serious reaction.
Studies in animals showed an increased risk of thyroid tumors. It is not known whether this occurs in humans.
Contact your provider if you experience:
Inflammation of the pancreas may occur.
Semaglutide may increase the risk of gallstones or other gallbladder conditions.
Low blood sugar may occur, particularly in patients who also take medications that lower blood sugar.
Severe nausea, vomiting, or diarrhea can lead to dehydration and may worsen kidney function in some individuals.
Stop using the medication and seek medical attention immediately if you experience:
Contact your provider if you notice changes in vision.
Notify your provider if you experience a rapid heartbeat while at rest.
Contact your provider if you experience new or worsening changes in mood or behavior.
Do not share injection pens or syringes with another person. Sharing devices may increase the risk of infection.
These effects are often mild to moderate and may decrease as your body adjusts to treatment.
If too much medication is taken, seek medical advice promptly or contact a poison control center.
This summary provides general information about semaglutide but does not include all available information about this medication.
Always follow the guidance of your healthcare provider and review the medication information provided with your prescription.
Your provider can help determine whether this treatment is appropriate for you.
Do not use tirzepatide if:
If you are unsure whether any of these apply to you, speak with your healthcare provider before starting treatment.
Tirzepatide is typically administered as a once-weekly subcutaneous injection.
The medication may be injected into the:
It may be taken with or without food. In many treatment plans, the dosage may be gradually adjusted over time depending on your provider’s clinical guidance.
Do not change your dose or stop treatment without first speaking with your healthcare provider.
Tirzepatide may interact with other medications. Be sure to tell your provider about all medications and supplements you take, including:
Certain medications may require additional monitoring, including:
Tirzepatide may slow stomach emptying, which can affect how some oral medications are absorbed.
If you take oral medications where timing is important, your provider can guide you on how to schedule them.
Tell your provider if you have ever had:
Sharing your full medical history helps ensure the safest treatment plan.
Tell your provider if you are:
Tirzepatide should not be used during pregnancy, as weight loss during pregnancy may pose risks to an unborn baby.
Because tirzepatide may remain in the body for an extended period, treatment is typically discontinued well in advance of a planned pregnancy. Follow your provider’s guidance on timing.
If you are breastfeeding or planning to breastfeed, discuss the best feeding options with your provider before starting treatment.
Seek immediate medical care if you are experiencing a medical emergency.
Studies in animals showed an increased risk of thyroid tumors. It is not known whether this occurs in humans.
Contact your provider if you experience:
Inflammation of the pancreas may occur.
Contact your provider right away if you experience:
Tirzepatide may increase the risk of gallstones or other gallbladder conditions.
Contact your provider if you experience:
Low blood sugar may occur, particularly in patients who also take medications that lower blood sugar.
Symptoms may include:
Severe nausea, vomiting, or diarrhea can lead to dehydration and may worsen kidney function in some individuals. Stay well hydrated and contact your provider if symptoms persist.
Stop using the medication and seek medical attention immediately if you experience:
Contact your provider if you notice changes in vision.
Notify your provider if you experience a rapid heartbeat while at rest.
Contact your provider if you experience new or worsening changes in mood or behavior.
Tirzepatide may reduce appetite. In some patients, reduced intake combined with nausea or diarrhea can increase the risk of dehydration. Drink fluids regularly and contact your provider if you are unable to keep fluids down.
Do not share injection pens or syringes with another person. Sharing devices may increase the risk of infection.
These effects are often mild to moderate and may decrease as your body adjusts to treatment.
If too much medication is taken, seek medical advice promptly or contact a poison control center.
This summary provides general information about tirzepatide but does not include all available information about this medication.
Always follow the guidance of your healthcare provider and review the medication information provided with your prescription.
Your provider can help determine whether this treatment is appropriate for you.
Please Contact Us at 1-855-495-3111
Or Email Us at support@newself.com
NewSelf Limited LLC is a technology platform that collaborates with independent healthcare professionals to deliver top-notch services through our NewSelf Patient Management System. We do not directly offer medical or pharmacy services, and payment does not guarantee that a prescription will be written or medication dispensed. Independent providers handle all medical services. The information provided on this site is for informational purposes only and is not a substitute for professional medical advice. For any health-related concerns, please consult your licensed healthcare provider. Our platform serves as an advertisement for services, not for specific medications.
-Photoroom.webp)
